Covered recipient · General Payments record
MATTHEW HADILAKSONO
Allopathic & Osteopathic Physicians Physical Medicine & Rehabilitation
General Payments · PY2018–2024
$5,739.98
- Reported across 125 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $769.51 | 16 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Abbott Laboratories | $460.30 | 9 |
| BOSTON SCIENTIFIC CORPORATION | $82.00 | 1 |
| Nalu Medical, Inc. | $72.53 | 1 |
| SPR Therapeutics, Inc | $62.74 | 1 |
| ABBVIE INC. | $29.88 | 1 |
| SI-BONE, INC. | $21.92 | 1 |
| Avanos Medical | $20.60 | 1 |
| Averitas Pharma Inc. | $19.54 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (16)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Abbott Laboratories | $103.96 | 02/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1124898005 | CMS |
| Abbott Laboratories | $129.54 | 04/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1124898007 | CMS |
| Abbott Laboratories | $22.64 | 05/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1124898009 | CMS |
| Abbott Laboratories | $6.00 | 05/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1124898011 | CMS |
| Abbott Laboratories | $5.15 | 05/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1124898013 | CMS |
| Abbott Laboratories | $22.22 | 06/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1124898015 | CMS |
| Abbott Laboratories | $17.01 | 07/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1124898017 | CMS |
| Abbott Laboratories | $135.92 | 10/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1134594547 | CMS |
| Abbott Laboratories | $17.86 | 10/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1124898019 | CMS |
| ABBVIE INC. | $29.88 | 01/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103860101 | CMS |
| Avanos Medical | $20.60 | 03/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1149306081 | CMS |
| Averitas Pharma Inc. | $19.54 | 02/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1133428711 | CMS |
| Boston Scientific Corporation | $82.00 | 06/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1092724832 | CMS |
| Nalu Medical, Inc. | $72.53 | 10/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1133995365 | CMS |
| SI-BONE, INC. | $21.92 | 10/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1120070780 | CMS |
| SPR Therapeutics, Inc | $62.74 | 10/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104955928 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.